FHC
VYGR icon

First Horizon Corporation’s Voyager Therapeutics VYGR Stock Holding History

First Horizon Corporation’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$0 Buy
+96
New +$435 ﹤0.01% 1230

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

First Horizon Corporation's VYGR Position: Q2 2021 in Review

First Horizon Corporation opened a new position in Voyager Therapeutics (VYGR) in Q2 2021: 96 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1230 among its holdings.

78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

  • First Horizon Corporation held 96 shares of Voyager Therapeutics worth $0 as of Q2 2021.
  • Voyager Therapeutics was a new First Horizon Corporation position in Q2 2021.
  • Voyager Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #1230 holding.
  • 78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.